Status:
COMPLETED
Prevention of CR-POPF in PD With the Technique of Connexion the Pancreatic Duct to Jejunum Stented (CONDUCTJE-ST).
Lead Sponsor:
Instituto de Investigación Sanitaria Aragón
Conditions:
Pancreas Disease
Fistula Pancreatic
Eligibility:
All Genders
18-84 years
Brief Summary
Objective: To assess the efficacy of the "connexion pancreatic duct to jejunum stented (CONDUCTJE-ST)" technique to prevent clinically relevant postoperative pancreatic fistula (CR-POPF) after pancrea...
Detailed Description
From January 2018 to February 2020, a PD was performed with the CONDUCTJE-ST technique in 50 consecutive patients by the same surgical team, whose main surgeon has make more than 250 PD, in our Hepato...
Eligibility Criteria
Inclusion
- age\> 18 years
- informed surgical and anesthetic consents
- scheduled surgical intervention
- intention to carry out PD with the CONDUCTJE-ST technique
Exclusion
- emergency PD
- performing another pancreatic resection technique other than PD
- associated resection of another viscus
- metastasis or locally advanced unresectable tumor detected during surgery.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04898517
Start Date
January 1 2018
End Date
February 28 2021
Last Update
May 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Hospital Lozano Blesa
Zaragoza, Spain, 50009